Your browser doesn't support javascript.
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.
Zeng, Cong; Evans, John P; Chakravarthy, Karthik; Qu, Panke; Reisinger, Sarah; Song, No-Joon; Rubinstein, Mark P; Shields, Peter G; Li, Zihai; Liu, Shan-Lu.
  • Zeng C; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA.
  • Evans JP; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA; Molecular, Cellular and Developmental Biology Program, Ohio State University, Columbus, OH 43210, USA.
  • Chakravarthy K; Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Qu P; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA.
  • Reisinger S; Comprehensive Cancer Center, James Cancer Hospital, Ohio State University, Columbus, OH 43210, USA.
  • Song NJ; Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Rubinstein MP; Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Shields PG; Comprehensive Cancer Center, James Cancer Hospital, Ohio State University, Columbus, OH 43210, USA. Electronic address: Peter.Shields@osumc.edu.
  • Li Z; Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA. Electronic address: Zihai.Li@osumc.edu.
  • Liu SL; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, Ohio State University, Columbus, OH 43210, USA; Department of M
Cancer Cell ; 40(2): 117-119, 2022 02 14.
Article in English | MEDLINE | ID: covidwho-1588170

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization, Secondary / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / Antibodies, Viral / Neoplasms Type of study: Observational study Topics: Vaccines / Variants Limits: Adult / Aged / Humans / Middle aged Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2021.12.014

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization, Secondary / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / Antibodies, Viral / Neoplasms Type of study: Observational study Topics: Vaccines / Variants Limits: Adult / Aged / Humans / Middle aged Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2021.12.014